Home
About the Program
Structure
Calendar 2017
Calendar 2016
Calendar 2015
Calendar 2014
Calendar 2013
Calendar 2012
Calendar 2011
Admissions
The Students
Class of 2017
Class of 2016
Class of 2015
Class of 2014
Class of 2013
Class of 2012
Class of 2011
Class of 2010
Class of 2009
Class of 2008
Class of 2007
Class of 2006
Class of 2005
Class of 2004
Class of 2003
Class of 2002
Class of 2001
Class of 2000
Class of 1999
Class of 1997
Class of 1996
Research and Faculty
Coordinating Committee
Module Coordinators
Publications
PhD Degrees Completed
Events and Highlights
All Time GABBAs
Contacts
Reserved Area
Forgot your password?
Class of 1997
Name
Alves, Pedro M. S.
Nationality
Portuguese
E-Mail
alvespms@yahoo.co.uk
1st Degree
Biology
University (1st Degree)
Oporto University
About the PhD
Field of Research
Tumor Immunology
Supervisor(s)
Kostas Kosmatopoulos, MD
Co-Supervisor(s)
Eduardo Guimaraes MD PhD; Angelo A Cardoso MD PhD
University
Porto
Laboratory
Dana-Farber Cancer Research (USA); INSERM (FRANCE); Ludwig Inst. For Cancer Research (SWITZERLAND); Inst. Suisse pour la Recherche du Cancer (SWITZERLAND); Univ. Catholique de Louvain - Inst. Christian de Duve (BELGIUM)
Date of Thesis Defence
2003-03-27
After the PhD (Current Situation)
Position
Head Clinical Immunology, Cancer Immunotherapeutics BU.
Institution
GlaxoSmithKline Vaccines
View Institution website
City
Rixensart
Country
Belgium

Relevant Publications
ALVES PM, FAURE O, GRAFF-DUBOIS S, GROSS DA, CORNET S, CHOUAIB S, MICONNET I, LEMONNIER FA, KOSMATOPOULOS K. EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes. Cancer Res. 2003 Dec 1;63(23):8476-80.
PEDRO MS ALVES, OLIVIER FAURE, STEPHANIE GRAFF-DUBOIS, SEBASTIEN CORNET, IRENA BOLONAKIS, DAVID-ALEXANDRE GROSS, ISABELLE MICONNET, SALEM CHOUAIB, FRANCOIS A LEMONNIER, KOSTAS KOSMATOPOULOS. STEAP, an overexpressed tumor antigen of prostate, can be target of human CD8+ T cells. Cancer Immunology Immunotherapy, in press.
Alves PM, Levy N, Bouzourene H, Viatte S, Bricard G, Ayyoub M, Vuilleumier H, Givel JC, Halkic N, Speiser DE, Romero P, Levy F.
Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer.
Cancer Immunol Immunother. 2007 Jun;56(6):839-47
Alves PM, Viatte S, Fagerberg T, Michielin O, Bricard G, Bouzourene H, Vuilleumier H, Kruger T, Givel JC, Levy F, Speiser DE, Cerottini JC, Romero P.
Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients.
Cancer Immunol Immunother. 2007 Nov;56(11):1795-805
Viatte S, Alves PM, Romero P.
Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.
Immunol Cell Biol. 2006 Jun;84(3):318-30

Publications
CARVALHO F, DAVID L, AUBERT JP, LOPEZ-FERRER A, DE BOLOS C, REIS CA, GARTNER F, PEIXOTO A, ALVES P, SOBRINHO-SIMOES M.Mucins and mucin-associated carbohydrate antigens expression in gastric carcinoma cell lines.Virchows Arch. 1999 Nov;435(5):479-85.
P ALVES, P SOARES, E FONSECA, M SOBRINHO-SIMOES. Papillary thyroid carcinoma overexpressed fully and underglycosylated mucins together with native and sialylated simple mucins antigens and histoblood group antigens. Endocrine Pathology. 1999; 10: 315 -324
P ALVES, P SOARES, S ROSSI, E FONSECA, M SOBRINHO-SIMOES. Clinicopathologic and prognostic significance in the expression of mucins, simple mucins antigens and histoblood group antigens in papillary thyroid carcinoma. Endocrine Pathology. 1999; 10: 305 -314.
SCARDINO A., ALVES P., GROSS D.A., TOURDOT S., GRAFF-DUBOIS, S., CHOUAIB S., LEMMONIER F., NADLER L.M., CARDOSO A.A., KOSMATOPOULOS K. Identification of Novel HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other epithelial tumors. Eur. J. Immunol. 2001 Nov;31(11):3261-70.
SCARDINO A, GROSS DA, ALVES P, SCHULTZE JL, GRAFF-DUBOIS S, FAURE O, TOURDOT S, CHOUAIB S, NADLER LM, LEMONNIER FA, VONDERHEIDE RH, CARDOSO AA, KOSMATOPOULOS K. HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy. J Immunol. 2002 Jun 1;168(11):5900-6.

[more publications]
Last Update
2013-03-18 16:24:34

The responsibility for this page contents is entirely of the student/alumnus.
INSTITUTIONS INVOLVED
Program financially supported by
the National Foundation for
Science and Technology